Literature DB >> 17269936

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

J Astermark, X Wang, J Oldenburg, E Berntorp, A-K Lefvert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17269936     DOI： 10.1111/j.1538-7836.2007.02290.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  22 in total

1.  HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.

Authors:  R A Ettinger; E A James; W W Kwok; A R Thompson; K P Pratt
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

Review 2.  Violating the theory of single gene-single disorder: inhibitor development in hemophilia.

Authors:  Suad AlFadhli; Rasheeba Nizam
Journal:  Indian J Hematol Blood Transfus       Date:  2014-11-20       Impact factor: 0.900

3.  Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.

Authors:  Y Dargaud; A Pavlova; S Lacroix-Desmazes; K Fischer; M Soucie; S Claeyssens; D W Scott; R d'Oiron; G Lavigne-Lissalde; G Kenet; C Escuriola Ettingshausen; A Borel-Derlon; T Lambert; G Pasta; C Négrier
Journal:  Haemophilia       Date:  2016-01       Impact factor: 4.287

Review 4.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

Authors:  J N Lozier; P S Rosenberg; J J Goedert; I Menashe
Journal:  Haemophilia       Date:  2011-03-01       Impact factor: 4.287

Review 6.  FVIII inhibitors: pathogenesis and avoidance.

Authors:  Jan Astermark
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

7.  The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  Jan Astermark; Sharyne M Donfield; Edward D Gomperts; John Schwarz; Erika D Menius; Anna Pavlova; Johannes Oldenburg; Bailey Kessing; Donna M DiMichele; Amy D Shapiro; Cheryl A Winkler; Erik Berntorp
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

8.  Quantitation of anti-factor VIII antibodies in human plasma.

Authors:  Jolanta Krudysz-Amblo; Behnaz Parhami-Seren; Saulius Butenas; Kathleen E Brummel-Ziedins; Edward D Gomperts; Georges E Rivard; Kenneth G Mann
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

9.  Inhibitors of factor VIII in black patients with hemophilia.

Authors:  Kevin R Viel; Afshin Ameri; Thomas C Abshire; Rathi V Iyer; Raymond G Watts; Charles Lutcher; Cynthia Channell; Shelley A Cole; Karl M Fernstrom; Shelley Nakaya; Carol K Kasper; Arthur R Thompson; Laura Almasy; Tom E Howard
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

10.  F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.

Authors:  J Schwarz; J Astermark; E D Menius; M Carrington; S M Donfield; E D Gomperts; G W Nelson; J Oldenburg; A Pavlova; A D Shapiro; C A Winkler; E Berntorp
Journal:  Haemophilia       Date:  2012-09-07       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.